SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IMMC - Industry leading Diabetes Drug

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: David in Ontario who wrote (17)3/30/1999 12:32:00 PM
From: Rich Kaiser  Read Replies (4) of 55
 
Hi Dave,

It looks really good for IMMC for two reason:
1) The financial world has been putting out a lot of information, in a number of publication ,about the Drug industries low price stock in terms of their performances.
2)IMMC should be coming out with news because today BIotech had a release about signing a deal with a major player in Argentina. IMMC will receive 25% of the revenue generated from this agreement. This agreement and the pending agreement in Brazil will ensure that IMMC meet it earning expectation for 1999 around $0.25

I'm very excited about the whole situation... At these levels and with NO debt and small public float. IMMC should be a serious consideration.

With best Regards
Rich
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext